{"id":"https://openalex.org/W4390612166","doi":"https://doi.org/10.1080/00498254.2024.2302547","title":"Meeting report of the 4th European biotransformation workshop","display_name":"Meeting report of the 4th European biotransformation workshop","publication_year":2024,"publication_date":"2024-01-05","ids":{"openalex":"https://openalex.org/W4390612166","doi":"https://doi.org/10.1080/00498254.2024.2302547","pmid":"https://pubmed.ncbi.nlm.nih.gov/38178690"},"language":"en","primary_location":{"id":"doi:10.1080/00498254.2024.2302547","doi":"https://doi.org/10.1080/00498254.2024.2302547","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00498254.2024.2302547","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057363726","display_name":"Markus Walles","orcid":"https://orcid.org/0000-0001-8376-8311","observed_orcids":["https://orcid.org/0000-0001-8376-8311"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"M. Walles","raw_affiliation_strings":["Pharmacokinetic Sciences, Biomedical Research, Novartis, Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-8376-8311","affiliations":[{"raw_affiliation_string":"Pharmacokinetic Sciences, Biomedical Research, Novartis, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028286937","display_name":"Arno P\u00e4hler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"A. P\u00e4hler","raw_affiliation_strings":["F Hoffmann-La Roche AG Research and Development Division, Pharma Research and Early Development, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F Hoffmann-La Roche AG Research and Development Division, Pharma Research and Early Development, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063126822","display_name":"Emre Mehmet Isin","orcid":"https://orcid.org/0000-0003-3402-7685","observed_orcids":["https://orcid.org/0000-0003-3402-7685"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E.M. Isin","raw_affiliation_strings":["DMPK, Translational Medicine, Paris-Saclay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DMPK, Translational Medicine, Paris-Saclay, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038580147","display_name":"Marie M. Ahlqvist","orcid":"https://orcid.org/0000-0002-1246-4350","observed_orcids":["https://orcid.org/0000-0002-1246-4350"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Marie M. Ahlqvist","raw_affiliation_strings":["Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5057363726"],"corresponding_institution_ids":["https://openalex.org/I1283582996"],"apc_list":null,"apc_paid":null,"fwci":0.4069,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.49754861,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"54","issue":"5","first_page":"257","last_page":"262"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.7095000147819519,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.7095000147819519,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.26339998841285706,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.011099999770522118,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biotransformation","display_name":"biotransformation","score":0.984000027179718},{"id":"https://openalex.org/keywords/peptide-metabolites","display_name":"peptide metabolites","score":0.9330000281333923},{"id":"https://openalex.org/keywords/accelerator-mass-spectrometry","display_name":"accelerator mass spectrometry","score":0.968999981880188},{"id":"https://openalex.org/keywords/metabolic-profiling","display_name":"metabolite profiling","score":0.9010000228881836},{"id":"https://openalex.org/keywords/xenobiotic-metabolites","display_name":"xenobiotic metabolites","score":0.8029999732971191},{"id":"https://openalex.org/keywords/endogenous-metabolites","display_name":"endogenous metabolites","score":0.8709999918937683},{"id":"https://openalex.org/keywords/quantitative-nmr","display_name":"quantitative NMR","score":0.8730000257492065},{"id":"https://openalex.org/keywords/lc-icp-ms","display_name":"LC-ICP-MS","score":0.9909999966621399}],"concepts":[{"id":"https://openalex.org/C27881333","wikidata":"https://www.wikidata.org/wiki/Q864895","display_name":"Biotransformation","level":3,"score":0.9300909042358398},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.358414888381958},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33275726437568665},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27869024872779846},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16786229610443115},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.06262624263763428}],"mesh":[{"descriptor_ui":"D001711","descriptor_name":"Biotransformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002853","descriptor_name":"Chromatography, Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015262","descriptor_name":"Xenobiotics","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055432","descriptor_name":"Metabolomics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/00498254.2024.2302547","doi":"https://doi.org/10.1080/00498254.2024.2302547","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00498254.2024.2302547","pdf_url":null,"source":{"id":"https://openalex.org/S48760969","display_name":"Xenobiotica","issn_l":"0049-8254","issn":["0049-8254","1366-5928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica","raw_type":"journal-article"},{"id":"pmid:38178690","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38178690","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Xenobiotica; the fate of foreign compounds in biological systems","raw_type":"Conference Proceedings"},{"id":"pmh:oai:oak.novartis.com:52826","doi":null,"is_oa":false,"landing_page_url":"https://oak.novartis.com/52826/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400709","display_name":"The Novartis Repository (Novartis)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1283582996","host_organization_name":"Novartis (Switzerland)","host_organization_lineage":["https://openalex.org/I1283582996"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W2041417337","https://openalex.org/W2042014666","https://openalex.org/W2076816135","https://openalex.org/W2123941740","https://openalex.org/W2619821219","https://openalex.org/W2891669949","https://openalex.org/W4206296781","https://openalex.org/W4282932513","https://openalex.org/W4306154967","https://openalex.org/W4317479418"],"related_works":["https://openalex.org/W4402171222","https://openalex.org/W4317867726","https://openalex.org/W4223460018","https://openalex.org/W3186133247","https://openalex.org/W1964554382","https://openalex.org/W4386768745","https://openalex.org/W2479712067","https://openalex.org/W7159867078","https://openalex.org/W4412653268","https://openalex.org/W2916596586"],"abstract_inverted_index":{"1.":[0],"Challenges,":[1],"strategies":[2],"and":[3,13,51,86,97],"new":[4],"technologies":[5],"in":[6,24,40,66],"the":[7,16,27,36,49,76],"field":[8],"of":[9,38,78],"biotransformation":[10,63],"were":[11],"presented":[12],"discussed":[14],"at":[15,35],"fourth":[17],"European":[18],"Biotransformation":[19],"Workshop":[20],"which":[21],"was":[22],"held":[23],"collaboration":[25],"with":[26],"joint":[28],"ISSX/DMDG":[29],"meeting":[30,45],"on":[31],"June":[32],"15,":[33],"2023":[34],"University":[37],"Hertfordshire":[39],"Hatfield,":[41],"UK.2.":[42],"In":[43],"this":[44,54],"report":[46],"we":[47],"summarise":[48],"presentations":[50],"discussions":[52],"from":[53],"workshop.3.":[55],"The":[56],"topics":[57],"covered":[58],"are":[59],"listed":[60],"below:":[61],"Unusual":[62],"reactionsBiotransformation":[64],"Workflows":[65],"Discovery":[67],"utilising":[68],"various":[69],"softwares":[70],"for":[71,75,84],"structure":[72],"elucidationBiotransformation":[73],"software":[74],"identification":[77],"peptide":[79],"metabolitesAccelerator":[80],"Mass":[81],"Spectrometry":[82],"(AMS)":[83],"endogenous":[85],"xenobiotic":[87],"metabolite":[88],"profilingMetabolite":[89],"profiling":[90],"using":[91],"quantitative":[92],"Nuclear":[93],"magnetic":[94],"resonance":[95],"(NMR)":[96],"liquid":[98],"chromatography":[99],"coupled":[100,103],"to":[101],"inductively":[102],"plasma-mass":[104],"spectrometry":[105],"(LC-ICP-MS).":[106]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2024-01-07T00:00:00"}